Ketamine shortages are making it hard for patients to find this medication in 2026. Learn why Ketamine is so hard to find and what you can do about it.
You've got a valid prescription for Ketamine, but pharmacy after pharmacy tells you the same thing: "We don't have it in stock." It's frustrating, stressful, and unfortunately becoming a common experience for patients in 2026.
Whether you need Ketamine for a scheduled procedure, chronic pain management, or depression treatment, the supply problems are real. In this article, we'll explain exactly why Ketamine is so hard to find right now and what steps you can take to get your medication.
Ketamine is a dissociative anesthetic that has been used in medicine since the 1970s. It's FDA-approved as a general anesthetic for surgical and diagnostic procedures. Classified as a Schedule III controlled substance by the DEA, Ketamine works by blocking NMDA receptors in the brain, which affects how pain signals and mood-regulating chemicals like glutamate are processed.
Beyond anesthesia, Ketamine has gained significant attention for its off-label use in treating treatment-resistant depression, chronic pain conditions like complex regional pain syndrome (CRPS), and acute suicidal ideation. Its related medication, Esketamine (brand name Spravato), is FDA-approved specifically for treatment-resistant depression.
Ketamine is available as an injectable solution in various concentrations (10 mg/mL, 50 mg/mL, and 100 mg/mL), and through compounding pharmacies as oral lozenges, sublingual tablets, and nasal sprays for off-label psychiatric use.
There isn't just one reason Ketamine is in short supply. Several factors are working together to create the current shortage.
Over the past several years, the number of Ketamine infusion clinics and telehealth services prescribing compounded Ketamine for depression has exploded. What was once used primarily in operating rooms is now being prescribed by psychiatrists, pain specialists, and telehealth platforms nationwide. This massive increase in demand has strained the supply chain for injectable Ketamine.
The Ketamine supply chain depends on a handful of manufacturers, including Hikma, Eugia, and Fresenius Kabi. In 2025, Eugia discontinued its 100 mg/mL 10 mL vials, removing a key product from the market. Eugia has also reported shortages due to increased demand. When one manufacturer cuts production, the remaining suppliers can't always pick up the slack quickly enough.
The FDA has issued warnings about compounded Ketamine products, particularly at-home oral and nasal formulations. This increased regulatory scrutiny has affected the compounding pharmacy supply chain, creating uncertainty for patients who rely on these formulations for depression treatment.
As a Schedule III controlled substance, Ketamine comes with strict DEA requirements for storage, record-keeping, and distribution. Many retail pharmacies don't stock it at all because of these regulatory burdens. This means even when supply exists, it may not be available at your neighborhood pharmacy.
The shortage is real, but there are practical steps you can take right now.
Instead of calling pharmacy after pharmacy, use Medfinder to check which pharmacies near you have Ketamine in stock. It saves time and frustration by showing you real-time availability information.
Large chain pharmacies often have limited supplies of controlled substances. Independent pharmacies and specialty compounding pharmacies may have better access to Ketamine, especially compounded formulations like lozenges and sublingual tablets. Ask your prescriber if a compounding pharmacy is an option for your treatment.
Pharmacy staff are more likely to have time to check their stock and help you find solutions if you call early in the morning or during slower periods. Avoid calling during the lunch rush or late afternoon when pharmacies are busiest.
If you can't find Ketamine, your doctor may be able to suggest alternatives. For depression, Spravato (Esketamine) is an FDA-approved nasal spray that may be covered by insurance. For anesthesia, your anesthesiologist can use other agents like Propofol or Midazolam. For pain management, other NMDA-modulating options may be available.
If your pharmacy doesn't have the specific concentration you need, ask your prescriber if a different concentration would work. For example, if the 100 mg/mL vials are unavailable, the 50 mg/mL or 10 mg/mL solutions may still be in stock.
The Ketamine shortage in 2026 is driven by a perfect storm of increased demand, manufacturing changes, and regulatory pressures. While the situation is frustrating, you have options. Using tools like Medfinder, working with your prescriber, and exploring specialty pharmacies can help you get the medication you need.
For more details on the current shortage situation, check out our Ketamine shortage update for 2026. And if you're looking for ways to reduce your costs, read our guide on how to save money on Ketamine.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
